Abingworth — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
CRISPR Therapeutics AGOct 2016SEC filingmedium confidence
BiotechBasel
Sven Ante Lundberg(Executive Officer)Thomas Woiwode(Director)Pablo Cagnoni(Director)Bradley Bolzon(Director)N. Anthony Coles(Director)Kala Subramanian(Executive Officer)
Board seatKurt von Emster· per SEC Form D · $35M raise · filed Nov 2016
Co-investorsNew Enterprise Associates (NEA)SR One Capital ManagementVersant Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.